Scarica l'app Stockscreener
0.427
2.51%
-0.011
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Vaxart Inc Borsa (VXRT) Ultime notizie
Vaxart Announces Preliminary Results of Annual Meeting of Stockh - GuruFocus
Vaxart, Inc. Announces Results from 2025 Annual Meeting of Stockholders - Nasdaq
Vaxart Announces Preliminary Results of Annual Meeting of Stockholders - The Manila Times
Vaxart Faces Nasdaq Challenge as Shareholders Block Reverse Split Proposal at Annual Meeting - Stock Titan
Vaxart reports improved antibody response in norovirus vaccine trial By Investing.com - Investing.com India
Biotech Steals The Mid-Week Spotlight With Key Announcement - The Globe and Mail
Vaxart (VXRT) Unveils Promising Phase 1 Results for New Noroviru - GuruFocus
Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discu - GuruFocus
Vaxart Jumps 38% After Positive Norovirus Trial - Yahoo Finance
Vaxart soars on positive data from new norovirus vaccine trial - MSN
Vaxart (VXRT) Shares Soar After Promising Norovirus Vaccine Tria - GuruFocus
Vaxart, DoubleVerify, Cracker Barrel - TradingView
Vaxart stock soars after positive Phase 1 norovirus vaccine results By Investing.com - Investing.com South Africa
Vaxart's Oral Norovirus Vaccine Pills Meet Primary Immunological Endpoint in Phase 1 Trial - marketscreener.com
Sector Update: Health Care Stocks Higher Pre-Bell Wednesday - MarketScreener
Vaxart stock soars after positive Phase 1 norovirus vaccine results - Investing.com
Vaxart reports improved antibody response in norovirus vaccine trial - Investing.com Australia
Vaxart Reports Positive Clinical Data Demonstrating that its Sec - GuruFocus
Vaxart Reports Positive Clinical Data Demonstrating Second-Generation Vaccine Technology Produces Stronger Antibody Responses Than First-Generation - marketscreener.com
Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology - The Manila Times
Vaxart Reports Positive Clinical Data Demonstrating that - GlobeNewswire
Breakthrough: New Oral Pill Vaccine Technology Delivers 141% Stronger Immune Response Against Norovirus - Stock Titan
Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discuss Topline Results from Its Phase I Norovirus Trial - GlobeNewswire
Vaxart to Reveal First-Ever Oral Norovirus Vaccine Trial Results: Key Data Coming Tomorrow - Stock Titan
Vaxart, Inc. (NASDAQ:VXRT) Shares Bought by Squarepoint Ops LLC - Defense World
Vaxart to Participate at the Jefferies Global Healthcare Conference on June 5, 2025 | VXRT Stock News - GuruFocus
Vaxart, Inc. (NASDAQ:VXRT) Sees Significant Increase in Short Interest - Defense World
Hagens Berman Sobol Shapiro LLP and Scott+Scott Attorneys at Law LLP Announce a Class Action for All Vaxart Shareholders that May Include You, Even if You Participated in the Previous Partial Settlement with Vaxart - Business Wire
Millennium Management LLC Decreases Stock Holdings in Vaxart, Inc. (NASDAQ:VXRT) - Defense World
Vaxart Announces Adjournment of Annual Meeting of Stockholders | - GuruFocus
Vaxart Announces Adjournment Of Annual Meeting Of Stockholders - marketscreener.com
Vaxart Announces Adjournment of Annual Meeting of Stockholders | VXRT Stock News - GuruFocus
Vaxart Annual Meeting Adjourned to June 13, 2025; Proxy Advisory Firms Support Proposal No. 2 - Nasdaq
Vaxart Announces Adjournment of Annual Meeting of Stockholders - GlobeNewswire
B. Riley Has Positive Forecast for Vaxart Q3 Earnings - Defense World
FY2029 Earnings Estimate for Vaxart Issued By B. Riley - Defense World
Vaxart stock climbs on positive study of pill-based norovirus vaccine - MSN
Zoom Rises 8% in 3 Months: Here's Why You Should Buy the Stock Now - The Globe and Mail
Vaxart seeks shareholder nod for reverse stock split By Investing.com - Investing.com South Africa
Vaxart to Participate at the Jefferies Global Healthcare Conference on June 5, 2025 - The Manila Times
Vaxart Leaders Set for Key Fireside Chat at Major Healthcare Conference: What to Expect - Stock Titan
Vaxart (VXRT) Releases Video Update Urging Support for Reverse S - GuruFocus
Vaxart seeks shareholder nod for reverse stock split - Investing.com Australia
Vaxart's Founder and Chief Scientific Officer Provides Video Update to Stockholders | VXRT Stock News - GuruFocus
Vaxart’s Founder and Chief Scientific Officer Provides Video Update to Stockholders - GlobeNewswire
Vaxart Founder Makes Urgent Appeal: Critical Nasdaq Compliance Vote Deadline Approaches - Stock Titan
Vaxart Discusses Reverse Stock Split and Capital Raise - TipRanks
Vaxart Answers Additional Frequently Asked Questions from Retail Investors - GlobeNewswire
Vaxart (VXRT) Addresses Stockholder Concerns Ahead of Annual Mee - GuruFocus
Vaxart Begins Phase 2b Trial for Oral COVID-19 Vaccine - TipRanks
Vaxart (VXRT) Addresses Stockholder Concerns Ahead of Annual Meeting | VXRT Stock News - GuruFocus
Vaxart Reveals New Split Ratio Details as Nasdaq Delisting Deadline LoomsCEO Urges Action - Stock Titan
0.68%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):